Pseudomonas aeruginosa infection after pancreatoduodenectomy: Risk factors and clinic impacts

Surgical Infections

Volumn 16, Issue 6, 2015, Pages 769-774

  Zhang, Jun Feng ^a   Zhu, Hong Yan ^b   Sun, Yong Wei ^a   Liu, Wei ^a   Huo, Yan Miao ^a   Liu, De Jun ^a   Li, Jiao ^a   Hua, Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b First People's Hospital of Suqian   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ABDOMINAL DRAINAGE; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BLOOD; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RISK ASSESSMENT; SPUTUM; STOMACH EMPTYING; STOMACH FUNCTION DISORDER; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SURGICAL WOUND; ADVERSE EFFECTS; CHINA; DRUG EFFECTS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PREVALENCE; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHINA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS;

EID: 84948708400     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.041     Document Type: Article

References (26)

1. Xiao M, Wang Y, Yang QW, et al. Antimicrobial susceptibility of Pseudomonas aeruginosa in China: A review of two multicentre surveillance programmes, and application of revised CLSI susceptibility breakpoints. Int J Antimicrob Agents 2012;40:445-449.
2. Zhang H, Yang Q, Xiao M, et al. Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011. Chin Med J (Engl) 2014;127:2429-2433.
3. Limongelli P, Pai M, Bansi D, et al. Correlation between preoperative biliary drainage, bile duct contamination, and postoperative outcomes for pancreatic surgery. Surgery 2007;142:313-318.
4. Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreatoduodenectomyassociated morbidity in 300 consecutive patients. Ann Surg 2001;234:47-55.
5. Bassi C, Dervenis C, Butturini G, et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005;138:8-13.
6. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): An International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142:20-25.
7. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761-768.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
10. Sugiura T, Uesaka K, Ohmagari N, et al. Risk factor of surgical site infection after pancreaticoduodenectomy. World J Surg 2012;36:2888-2894.
11. Ledizet M, Murray TS, Puttagunta S, et al. The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients. PLoS One 2012;7:e49578.
12. Parkins MD, Gregson DB, Pitout JD, et al. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection. Infection 2010;38:25-32.
13. Watters C, DeLeon K, Trivedi U, et al. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med Microbiol Immunol 2013;202:131-141.
14. Sugiura T, Uesaka K, Ohmagari N, et al. Risk factor of surgical site infection after pancreaticoduodenectomy. World J Surg 2012;36:2888-2894.
15. Lee YL, Chen YS, Toh HS, et al. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010. Int J Antimicrob Agents 2012;40:S29-36.
16. Bassi C, Molinari E, Malleo G, et al. Early versus late drain removal after standard pancreatic resections: Results of a prospective randomized trial. Ann Surg 2010; 252:207-214.
17. Kawai M, Tani M, Terasawa H, et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: Prospective study for 104 consecutive patients. Ann Surg 2006; 244:1-7.
18. Strateva T, Yordanov D. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J Med Microbiol 2009;58: 1133-1148
19. Miliani K, L'Heriteau F, Lacave L, et al. Antimicrobial Surveillance Network Study Group. Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France. J Hosp Infect 2011;77:343-347.
20. Voor In t'Holt AF, Severin JA, Lesaffre EM, et al. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2014;58:2626-2637.
21. Roulin D, Cerantola Y, Demartines N, et al. Systematic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg 2011;15:1055-1062.
22. Qu H, Sun GR, Zhou SQ, et al. Clinical risk factors of delayed gastric emptying in patients after pancreaticoduodenectomy: A systematic review and meta-analysis. Eur J Surg Oncol 2013;39:213-223.
23. Yamashita K, Sasaki T, Itoh R, et al. Pancreatic fistulae secondary to trypsinogen activation by Pseudomonas aeruginosa infection after pancreatoduodenectomy. J Hepatobiliary Pancreat Sci 2015;22:454-462. doi: 10.1002/jhbp.223.
24. Tam VH, Rogers CA, Chang KT, et al. Impact of multidrug- resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother 2010;54: 3717-3722.
25. Morata L, Cobos-Trigueros N, Martinez JA, et al. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2012; 56:4833-4837.
26. Augustin P, Dinh AT, Valin N, et al. Pseudomonas aeruginosa post-operative peritonitis: Clinical features, risk factors, and prognosis. Surg Infect 2013;14:297-303.